REGISTERED
on 11 Jun 2019
Last Applicant/ Owned by
Newcastle Helix Newcastle upon Tyne NE4 5BX
GB
Serial Number
79240249 filed on 17th May 2018
Registration Number
5772193 registered on 11th Jun 2019
Correspondent Address
Boston, MA 02210-2206
UNITED STATES
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
IKSUDA THERAPEUTICS
Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; medical and pharmaceutical research services; research and development of vaccines and medicines; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biothera Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; medical and pharmaceutical research services; research and development of vaccines and medicines; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; scientific research; pharmaceutical research; biological research; biotechnology testing services namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; medical research services in the field of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines and gene therapy; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; information, advisory and consultancy services relating to the aforesaid
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [016]
Paper Goods and Printed Material
Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceuticals for the treatment of cancer; pharmaceuticals and medical preparations for the treatment of inflammatory diseases; vaccines for the treatment of cancer; vaccines for the treatment of gene and cell therapy; vaccines for the treatment of inflammatory diseases; pharmaceutical and medical preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical products for the prevention and treatment of cancer; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of inflammatory diseases; hormones and analogues for medical purposes; biopharmaceutical and pharmaceutical gene and cell therapy products, namely, therapeutic pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; chemical preparations for scientific and industrial processes, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for industrial use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79240249
Mark Type
No Service Mark
Attorney Docket Number
No G08962000400
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Jun 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 12th Feb 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 22nd Jan 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 25th Oct 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 21st Sep 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| 21st Sep 2019 | FINAL DISPOSITION PROCESSED |
| 11th Sep 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 11th Jun 2019 | REGISTERED-PRINCIPAL REGISTER |
| 26th Mar 2019 | PUBLISHED FOR OPPOSITION |
| 26th Mar 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |